DE60209248D1 - Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen - Google Patents
Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionenInfo
- Publication number
- DE60209248D1 DE60209248D1 DE60209248T DE60209248T DE60209248D1 DE 60209248 D1 DE60209248 D1 DE 60209248D1 DE 60209248 T DE60209248 T DE 60209248T DE 60209248 T DE60209248 T DE 60209248T DE 60209248 D1 DE60209248 D1 DE 60209248D1
- Authority
- DE
- Germany
- Prior art keywords
- estra
- benzodioxol
- dien
- hydroxy
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01204072 | 2001-10-26 | ||
PCT/EP2002/011732 WO2003037354A1 (en) | 2001-10-26 | 2002-10-21 | USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60209248D1 true DE60209248D1 (de) | 2006-04-20 |
Family
ID=8181136
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60230936T Expired - Lifetime DE60230936D1 (de) | 2001-10-26 | 2002-10-21 | Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen |
DE60209248T Expired - Lifetime DE60209248D1 (de) | 2001-10-26 | 2002-10-21 | Verwendung von (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)-estra-4,9-dien-3-on zur behandlung von schweren depressionen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60230936T Expired - Lifetime DE60230936D1 (de) | 2001-10-26 | 2002-10-21 | Verwendung von (11beta, 17beta)-11-(1,3-Benzodioxol-5-yl)-17-Hydroxy-17-(1-Propinyl)-estra-4,9-dien-3-on zur Behandlung von schweren Depressionen |
Country Status (27)
Country | Link |
---|---|
US (1) | US20040266863A1 (de) |
EP (2) | EP1441739B1 (de) |
JP (1) | JP4647909B2 (de) |
KR (1) | KR20050038580A (de) |
CN (1) | CN100531738C (de) |
AT (2) | ATE317700T1 (de) |
AU (1) | AU2002348996B2 (de) |
BR (1) | BR0213466A (de) |
CA (1) | CA2463446C (de) |
CY (1) | CY1110173T1 (de) |
DE (2) | DE60230936D1 (de) |
DK (1) | DK1652526T3 (de) |
EC (1) | ECSP045080A (de) |
ES (1) | ES2319563T3 (de) |
HK (1) | HK1087357A1 (de) |
HR (1) | HRP20040370B1 (de) |
HU (1) | HUP0500070A3 (de) |
IL (2) | IL161248A0 (de) |
IS (1) | IS2702B (de) |
MX (1) | MXPA04003781A (de) |
NO (1) | NO332978B1 (de) |
NZ (1) | NZ532429A (de) |
PL (1) | PL206687B1 (de) |
PT (1) | PT1652526E (de) |
RU (1) | RU2302245C2 (de) |
WO (1) | WO2003037354A1 (de) |
ZA (1) | ZA200403088B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050080061A1 (en) * | 2003-07-23 | 2005-04-14 | Corcept Therapeutics, Inc. | Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
AU2011236053B2 (en) * | 2004-11-19 | 2014-06-26 | Merck Sharpe & Dohme B.V. | Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
CN103316019B (zh) * | 2004-11-19 | 2015-10-28 | 默沙东有限责任公司 | 用于治疗抑郁症的包含选择性5-羟色胺再摄取抑制剂和糖皮质激素受体拮抗剂的药物组合 |
JP2009535430A (ja) * | 2006-05-02 | 2009-10-01 | コーセプト セラピューティクス, インコーポレイテッド | Il−2を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターiiアンタゴニストの使用 |
US8658128B2 (en) | 2011-02-03 | 2014-02-25 | Pop Test Cortisol Llc | System and method for diagnosis and treatment |
EP2699245A4 (de) * | 2011-04-18 | 2014-12-10 | Pop Test Cortisol Llc | Behandlung von haarausfall |
US8986677B2 (en) * | 2012-07-30 | 2015-03-24 | Pop Test Cortisol Llc | Therapeutic compositions and methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4814333A (en) * | 1987-07-28 | 1989-03-21 | The Trustees Of Dartmouth College | Method for treatment of hypercortisolemic, depressed patients |
IL118974A (en) * | 1995-08-17 | 2001-09-13 | Akzo Nobel Nv | History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them |
DE19727772A1 (de) * | 1997-06-30 | 1999-01-28 | Forschungszentrum Juelich Gmbh | Magnetflußsensor mit ringförmiger Sonde |
ATE332696T1 (de) * | 1997-10-06 | 2006-08-15 | Univ Leland Stanford Junior | Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen |
PT1370268E (pt) * | 2001-03-23 | 2009-08-26 | Corcept Therapeutics Inc | Métodos de tratamento de perturbações de stress usando antagonistas específicos dos receptores de glucocorticóides |
WO2002096433A1 (en) * | 2001-05-04 | 2002-12-05 | Corcept Therapeutics, Inc. | Methods for treating delirium using glucocorticoid receptor-specific antagonists |
CA2459033C (en) * | 2001-08-31 | 2012-05-22 | Corcept Therapeutics, Inc. | Methods for inhibiting cognitive deterioration in adults with down's syndrome |
-
2002
- 2002-10-21 KR KR1020047006050A patent/KR20050038580A/ko not_active Application Discontinuation
- 2002-10-21 CN CNB028210417A patent/CN100531738C/zh not_active Expired - Fee Related
- 2002-10-21 EP EP02781273A patent/EP1441739B1/de not_active Withdrawn - After Issue
- 2002-10-21 JP JP2003539697A patent/JP4647909B2/ja not_active Expired - Fee Related
- 2002-10-21 CA CA2463446A patent/CA2463446C/en not_active Expired - Fee Related
- 2002-10-21 AT AT02781273T patent/ATE317700T1/de active
- 2002-10-21 ES ES06101005T patent/ES2319563T3/es not_active Expired - Lifetime
- 2002-10-21 IL IL16124802A patent/IL161248A0/xx unknown
- 2002-10-21 DE DE60230936T patent/DE60230936D1/de not_active Expired - Lifetime
- 2002-10-21 NZ NZ532429A patent/NZ532429A/en not_active IP Right Cessation
- 2002-10-21 DE DE60209248T patent/DE60209248D1/de not_active Expired - Lifetime
- 2002-10-21 RU RU2004116082/15A patent/RU2302245C2/ru not_active IP Right Cessation
- 2002-10-21 EP EP06101005A patent/EP1652526B1/de not_active Expired - Lifetime
- 2002-10-21 BR BR0213466-7A patent/BR0213466A/pt not_active IP Right Cessation
- 2002-10-21 HU HU0500070A patent/HUP0500070A3/hu unknown
- 2002-10-21 WO PCT/EP2002/011732 patent/WO2003037354A1/en not_active Application Discontinuation
- 2002-10-21 US US10/493,981 patent/US20040266863A1/en not_active Abandoned
- 2002-10-21 PL PL369261A patent/PL206687B1/pl not_active IP Right Cessation
- 2002-10-21 PT PT06101005T patent/PT1652526E/pt unknown
- 2002-10-21 AU AU2002348996A patent/AU2002348996B2/en not_active Ceased
- 2002-10-21 MX MXPA04003781A patent/MXPA04003781A/es active IP Right Grant
- 2002-10-21 AT AT06101005T patent/ATE420649T1/de active
- 2002-10-21 DK DK06101005T patent/DK1652526T3/da active
-
2004
- 2004-03-31 IS IS7204A patent/IS2702B/is unknown
- 2004-04-01 IL IL161248A patent/IL161248A/en not_active IP Right Cessation
- 2004-04-22 ZA ZA200403088A patent/ZA200403088B/en unknown
- 2004-04-23 EC EC2004005080A patent/ECSP045080A/es unknown
- 2004-04-23 NO NO20041651A patent/NO332978B1/no not_active IP Right Cessation
- 2004-04-26 HR HRP20040370AA patent/HRP20040370B1/xx not_active IP Right Cessation
-
2006
- 2006-08-29 HK HK06109619.6A patent/HK1087357A1/xx not_active IP Right Cessation
-
2009
- 2009-02-02 CY CY20091100116T patent/CY1110173T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20042811L (no) | Substituerte henzoksazoler og analoger som estrogene midler | |
HUP0302093A2 (hu) | Konjugált ösztrogének és medroxi-progeszteron-acetát alkalmazása hormonpótló terápiában használható gyógyszerkészítmény előállítására | |
CY1104981T1 (el) | Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων | |
HK1087357A1 (en) | Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1- propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder. | |
ES2124905T3 (es) | Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad. | |
MXPA04005784A (es) | 2-fenilbenzofuranos sustituidos como agentes estrogenitos. | |
ATE233754T1 (de) | Diphenyl-piperidin derivate | |
BR0213684A (pt) | Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas | |
HUP0500346A2 (hu) | Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására | |
NO20014855L (no) | N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister | |
HUP0203338A2 (hu) | Integrin receptor ligandumok | |
MX2007004461A (es) | Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico. | |
ATE419855T1 (de) | Therapie für hormonersatz und depression enthaltend dienogest | |
NO20022712L (no) | Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene | |
DK1090028T3 (da) | Umættede 14,15-cyclopropano-androstaner, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser | |
NO974256L (no) | Anvendelse av anti-östrogener som befruktningshindrende midler for menn | |
ATE218366T1 (de) | Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8372 | Publication of ep patent withdrawn |